SURVEILLANCE OF ANTIBIOTIC RESISTANCE IN CLINICAL ISOLATES OF STREPTOCOCCUS PNEUMONIAE COLLECTED IN BELGIUM DURING WINTER 2000-2001

REFERENCES

• Hansman D, Bullen MM. A resistant pneumococcus. Lancet. 1967; ii: 264–5.
   Google Scholar
• Vanhoof R, Christiaens F, Dierickx R, Coignau H, Butzler JP. hi vitro evaluation of the antibiotic susceptibility of Streptococcus pneumoniae: pneumococci relatively resistant to penicillin in Brussels. Acta Clin Belg. 1980; 35: 343–8.
   Web of Science ®Google Scholar
• Verhaegen J, Glupczynski Y, Verbist L, et al. Capsular types and antibiotic susceptibility of pneumococci isolated from patients in Belgium with serious infections, 1980-1993. Clin Infect Dis. 1995; 20: 1339–45.
   Web of Science ®Google Scholar
• Vanhoof R, Carpentier M, Glupczynski Y, et al. hi vitro suscep-tibility of 176 clinical isolates of Streptococcus pneumoniae to 11 B-lactams, erythromycin ad tetracycline. Acta Clin Belg. 1996; 51: 377–85.
   PubMed Web of Science ®Google Scholar
• Vanhoof R, Carpentier M, Glupczynski Y, et al.. Surveillance of pneumococcal resistance in Belgium during winter 1996-1997. Acta Clin Belg. 1998; 53: 275–81.
   PubMed Web of Science ®Google Scholar
• Vanhoof R, Carpentier M, Fagnart O. et al. hi vitro study of the antimicrobial activity of various antibiotics against clinical iso-lates of Streptococcus pneumoniae from Belgium collected dur-ing winter 1998-1999. Acta Clin Belg. 2000; 55: 312–21.
   PubMed Web of Science ®Google Scholar
• Verhaegen J, Vandeven J, Verbiest N, Van Eldere J, Verbist L. Evolution of Streptococcus pneumoniae serotypes and antibi-otic resistance in Belgium - update (1994-98). Clin Microbiol Infect. 2000; 6: 308–15.
   PubMed Web of Science ®Google Scholar
• National Committee for Clinical Laboratory Standards. Meth-ods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. NCCLS Document M7-A4, vol. 17 No. 2, Villanova, PA, 1997.
   Google Scholar
• National Committee for Clinical Laboratory Standards. Perform-ance standards for antimicrobial susceptibility testing. NCCLS Document M100-S10, Vol. 20, No. 2, Wayne PA, 2000.
   Google Scholar
• Verhaegen J. Streptococcus pneumoniae. In: Ducoffre G, Ed. Surveillance van infectieuze aandoeningen door een netwerk van laboratoria voor Microbiologie 2000 + epidemiologische trends 1983–1999. IPH/EPI Reports Nr. 2001–018; Depot number D/ 2001/2505/28.
   Google Scholar
• Verhaegen J. Streptococcus pneumoniae. In: Ducoffre G, Ed. Surveillance van infectieuze aandoeningen door een netwerk van laboratoria voor Microbiologie 2001 +Voorlopig rapport. Ref. VVIV/3112/AM/200209.
   Google Scholar
• Verhaegen J, Verbist L. In-vitro activities of 16 non-B-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae. J Antimicrob Chemother. 1999; 43: 563–7.
   PubMed Web of Science ®Google Scholar
• Brueggemans AB, Coffmann SL, Rhomberg P. et al. Fluoroquinolone resistance in Streptococcus pneumoniae in the United States since 1994-1995. Antimicrob Agents Chemother. 2002; 46: 680–8.
   Web of Science ®Google Scholar
• Hoban DJ, Bouchillon SK, Karlowsky JA, et al. A comparative in vitro surveillance study of gemifloxacin activities against 2,632 recent Streptococcus pneumoniae isolates from across Europe, North America, and South America. Antimicrob Agents Chemother. 2000; 44: 3008–11.
   Web of Science ®Google Scholar
• Ho PL, Yung RVVH, Tsang DNC, et al. Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong-Kong multicentre study in 2000. J Antimicrob Chemother. 2001; 48: 659–65.
   PubMed Web of Science ®Google Scholar
• Bast DJ, De Azevedo JCS, Tam TY, et al. Interspecies recombi-nation contributes minimally to fluoroquinolone resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother. 2001; 45: 2631–4.
   Web of Science ®Google Scholar
• Ferrandiz MJ, Fenoll A, Linares J, De la Campa AG. Horizontal transfer of parC and gyrA in fluoroquinolone resistant clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother. 2000; 44: 840–7.
   Google Scholar
• Janoir C, Podglajen I, Kitzis MD, Poyart C, Gutmann L. In vitro exchange of fluoroquinolone resistance determinants between Streptococcus pneumoniae and viridans streptococci and genomic organization of the parE-parC region in Streptococcus mitis. J Infect Dis. 1999 ;180 : 555–8.
   Google Scholar
• Ho PL, Tse WS, Tsang KW, et al. Risk factors for acquisition of levofloxacin resistant Streptococcus pneumoniae: a case con-trol study. Clin Infect Dis. 2001 ; 32 : 701–7.
   PubMed Web of Science ®Google Scholar
• Chardon H, Fosse T, Laurans G, et al. A 1-year study of antibi-otic resistance among paediatric pneumococcal isolates in 1995 from four regions of France. Int J Antimicrob Agents. 1999, 13: 109–15.
   PubMed Web of Science ®Google Scholar
• Yagupsky P, Porat N, Fraser D, et al. Acquisition, carriage, and transmission of pneumococci with decreased antibiotic suscep-tibility in young children attending a day care facility in South-ern Israel. J Infect Dis. 1998; 177: 1003–12.
   PubMed Web of Science ®Google Scholar